Literature DB >> 20160537

Hypertensive crisis.

Maria Alexandra Rodriguez1, Siva K Kumar, Matthew De Caro.   

Abstract

Hypertension is a common chronic medical condition affecting over 65 million Americans. Uncontrolled hypertension can progress to a hypertensive crisis defined as a systolic blood pressure >180 mm Hg or a diastolic blood pressure >120 mm Hg. Hypertensive crisis can be further classified as a hypertensive urgency or hypertensive emergency depending on end-organ involvement including cardiac, renal, and neurologic injury. The prompt recognition of a hypertensive emergency with the appropriate diagnostic tests and triage will lead to the adequate reduction of blood pressure, ameliorating the incidence of fatal outcomes. Severely hypertensive patients with acute end-organ damage (hypertensive emergencies) warrant admission to an intensive care unit for immediate reduction of blood pressure with a short-acting titratable intravenous antihypertensive medication. Hypertensive urgencies (severe hypertension with no or minimal end-organ damage) may in general be treated with oral antihypertensives as an outpatient. Rapid and short-lived intravenous medications commonly used are labetalol, esmolol, fenoldopam, nicardipine, sodium nitroprusside, and clevidipine. Medications such as hydralazine, immediate release nifedipine, and nitroglycerin should be avoided. Sodium nitroprusside should be used with caution because of its toxicity. The risk factors and prognosticators of a hypertensive crisis are still under recognized. Physicians should perform complete evaluations in patients who present with a hypertensive crisis to effectively reverse, intervene, and correct the underlying trigger, as well as improve long-term outcomes after the episode.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160537     DOI: 10.1097/CRD.0b013e3181c307b7

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  40 in total

Review 1.  Advances in management of acute hypertension: a concise review.

Authors:  David B Tulman; Stanislaw P A Stawicki; Thomas J Papadimos; Claire V Murphy; Sergio D Bergese
Journal:  Discov Med       Date:  2012-05       Impact factor: 2.970

2.  Sepsis-related hypertensive response: friend or foe?

Authors:  Mohamed Saleh
Journal:  BMJ Case Rep       Date:  2014-05-22

3.  Recognition and management of complications during moderate and deep sedation. Part 2: cardiovascular considerations.

Authors:  Daniel E Becker; Daniel A Haas
Journal:  Anesth Prog       Date:  2011

4.  48-year-old man with cough and leg swelling.

Authors:  Olufunso W Odunukan; Muaz M Abudiab; Lawrence J Sinak
Journal:  Mayo Clin Proc       Date:  2012-12       Impact factor: 7.616

Review 5.  Cardiovascular hypertensive emergencies.

Authors:  D P Papadopoulos; E A Sanidas; N A Viniou; V Gennimata; V Chantziara; I Barbetseas; T K Makris
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 6.  Acute hypertension: a systematic review and appraisal of guidelines.

Authors:  Kirk J Pak; Tian Hu; Colin Fee; Richard Wang; Morgan Smith; Lydia A Bazzano
Journal:  Ochsner J       Date:  2014

Review 7.  Hypertensive crisis in children.

Authors:  Jayanthi Chandar; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2011-07-20       Impact factor: 3.714

8.  Hypertensive crisis in children and adolescents.

Authors:  Tomáš Seeman; Gilad Hamdani; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

Review 9.  Is epistaxis associated with arterial hypertension? A systematic review of the literature.

Authors:  D Kikidis; K Tsioufis; V Papanikolaou; K Zerva; A Hantzakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-29       Impact factor: 2.503

10.  The Role of a Single Dose of Sublingual Nifedipine in Managing Hypertensive Emergencies in the Patients who Undergo Haemodialysis.

Authors:  Jagjit Singh; Rajiv Kumar; Vitul K Gupta; Arun Kumar Maria; Rubina Paul; Simerpreet Kaur; Prabhnoor Singh Hayer
Journal:  J Clin Diagn Res       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.